Chinese Journal of Tissue Engineering Research ›› 2016, Vol. 20 ›› Issue (53): 7985-7991.doi: 10.3969/j.issn.2095-4344.2016.53.012

Previous Articles     Next Articles

Effect of periprosthetic fracture on hip function after femoral neck-preserving total hip arthroplasty: study protocol for a prospective, single-center, self-controlled trial with 2-year follow-up

Qin Di, Han Yong-tai, Li Hui-jie   

  1. Department of Bone Diseases, Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei Province, China
  • Revised:2016-10-28 Online:2016-12-23 Published:2016-12-23
  • Contact: Han Yong-tai, Master, Chief physician, Professor, Master’s supervisor, Department of Bone Diseases, Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei Province, China
  • About author:Qin Di, Master, Attending physician, Department of Bone Diseases, Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei Province, China
  • Supported by:

    the Medical Science Research Project of Hebei Province in China, No. 20150267

Abstract:

BACKGROUND: Total hip replacement with a collum femoris preserving (CFP) short stem prosthesis can reportedly reduce postoperative complications and preserve maximum bone tissue for long-term revision. However, CFP replacement has a relatively high risk of intraoperative periprosthetic fractures that can seriously harm hip function recovery.

OBJECTIVE: To analyze risk factors for periprosthetic fractures and develop preventive measures to reduce postoperative complications.
METHODS: A prospective, single-center, self-controlled, open-label clinical study with 2-year follow-up will be carried out at the Department of Orthopedics, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China. We will analyze imaging data from 25 patients who undergo total hip replacement with the CFP prosthesis. Primary outcome measure is hip function recovery as assessed by Harris hip score preoperatively and 6, 12, and 24 months postoperatively. Secondary outcome measures include fracture severity as assessed by periprosthetic fracture classification according to the American Academy of Orthopaedic Surgeons guidelines, and bone healing as assessed by CT and radiographic findings preoperatively and 6, 12, and 24 months postoperatively, including parameters of the proximal and mesal medullary cavity of the fractured femur (width of the medullary cavity at the point 20 mm above the midpoint of the small trochanter, at the midpoint of the small trochanter, at the point 20 mm below the midpoint of the small trochanter, and at the fracture line; width of the corresponding prostheses), intertrochanteric width, femoral neck-stem angle, femoral neck anteversion, femoral neck length, ratio of the distal end of the prosthesis to the medullary space, and height of the femoral calcar. Other outcome measures are multiple logistic regression analysis results of risk factors for periprosthetic fracture during hip replacement, and the incidence of adverse events within 24 months postoperatively. This study was registered at ClinicalTrials.gov (NCT 02981823) on 24 November 2016. Approved by the Ethics Committee of the Third Hospital of Hebei Medical University, China (approval number: KE2016-011-1), the study protocol will be performed in accordance with the guidelines of the Declaration of Helsinki, formulated by the World Medical Association. Written informed consent will be obtained from all participants prior to the trial.
DISCUSSION: This study will be expected to provide references for reducing the incidence of periprosthetic fracture during hip replacement with the CFP prosthesis.

中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱骨折;内固定;数字化骨科;组织工程

Key words: Tissue Engineering, Arthroplasty, Replacement, Hip, Acetabulum

CLC Number: